NCT03333122

Brief Summary

The purpose of the study is to learn more about the quality of life and satisfaction with breast cancer surgical treatment and education from patient reported outcome data. The data and information obtained from breast cancer patients can be invaluable in counselling patients with a new diagnosis of breast cancer on their expected outcomes and results. The hypothesis is that using prospectively obtained data to guide surgical decision-making and optimize access to surgical procedures would improve the treatment of patients and would most likely positively impact the health-related quality of life in patients.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
575

participants targeted

Target at P75+ for all trials

Timeline
44mo left

Started Oct 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Oct 2017Jan 2030

First Submitted

Initial submission to the registry

October 30, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

October 31, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 6, 2017

Completed
12.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

May 7, 2025

Status Verified

May 1, 2025

Enrollment Period

12.2 years

First QC Date

October 30, 2017

Last Update Submit

May 5, 2025

Conditions

Keywords

Breast Cancer Breast-QBreast ReconstructionBreast Conserving TherapyMastectomy

Outcome Measures

Primary Outcomes (4)

  • Compare health-related quality of life outcomes using condition specific surveys among women undergoing breast conserving therapy, mastectomy alone, or mastectomy with reconstruction

    The BREAST-Q survey is used to determine differences in health-related of life between treatment groups.

    Up to 5 Years

  • Compare patient satisfaction with their treatment and result among women undergoing breast conserving therapy, mastectomy alone, or mastectomy with reconstruction

    The BREAST-Q survey is used to detect differences in patient satisfaction among the groups.

    Up to 5 Years

  • Determine the effect of time on patient reported outcomes

    Survey responses will be compared across time.

    Up to 5 Years

  • Patient satisfaction with breast cancer education and compare with source of information and socioeconomic status

    PS-CaTE survey is administered to assess patient satisfaction with breast cancer education.

    Up to 1 Year

Study Arms (3)

Breast Conserving Therapy

Patient who undergo breast conserving therapy or breast conserving therapy with oncoplastic therapies will complete the BREAST-Q Lumpectomy survey module.

Mastectomy

Patients who undergo mastectomy will complete the BREAST-Q Mastectomy survey module.

Mastectomy with Reconstruction

Patient who undergo breast reconstruction will complete the BREAST-Q Reconstruction survey module. This group will be further subdivided based on implant or autologous tissue reconstruction.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population consists of adult female patients who are diagnosed with breast cancer will be recruited from the Multidisciplinary Clinic at Henry Ford Health System.

You may qualify if:

  • Patients having surgery for breast cancer
  • Treatment must be performed within the Henry Ford Health System
  • Patients must be at least 18 years of age

You may not qualify if:

  • Male gender
  • Patients with non-operative management of breast cancer
  • Patients who are unable to complete the surveys, either by choice or because of limited English, Spanish, or Arabic proficiency
  • Patients who are unable to complete a preoperative survey
  • Patients with Stage IV or metastatic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Health System

Detroit, Michigan, 48202, United States

Location

Study Officials

  • Dunya Atisha, MD

    Henry Ford Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 30, 2017

First Posted

November 6, 2017

Study Start

October 31, 2017

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

January 1, 2030

Last Updated

May 7, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations